Locally advanced pancreatic cancer: neoadjuvant therapy with folfirinox results in resectability in 60% of the patients

Objective: For patients with locally advanced and unresectable pancreatic cancer (PDAC), neodadjuvant treatment and consecutive surgical exploration have been studied during the last decade with various neoadjuvant therapies including chemotherapy and combinations with radiation. Aim of the study wa...

Full description

Saved in:
Bibliographic Details
Main Authors: Hackert, Thilo (Author) , Sachsenmaier, Milena (Author) , Hinz, Ulf (Author) , Schneider, Lutz (Author) , Michalski, Christoph (Author) , Springfeld, Christoph (Author) , Strobel, Oliver (Author) , Jäger, Dirk (Author) , Ulrich, Alexis (Author) , Büchler, Markus W. (Author)
Format: Article (Journal)
Language:English
Published: September 2016
In: Annals of surgery
Year: 2016, Volume: 264, Issue: 3, Pages: 457-463
ISSN:1528-1140
DOI:10.1097/SLA.0000000000001850
Online Access:Verlag, Volltext: http://dx.doi.org/10.1097/SLA.0000000000001850
Verlag, Volltext: https://journals.lww.com/annalsofsurgery/Abstract/2016/09000/Locally_Advanced_Pancreatic_Cancer__Neoadjuvant.8.aspx
Get full text
Author Notes:Thilo Hackert, Milena Sachsenmaier, Ulf Hinz, Lutz Schneider, Christoph W. Michalski, Christoph Springfeld, Oliver Strobel, Dirk Jäger, Alexis Ulrich, Markus W. Büchler

MARC

LEADER 00000caa a2200000 c 4500
001 1569803692
003 DE-627
005 20240316100322.0
007 cr uuu---uuuuu
008 180213s2016 xx |||||o 00| ||eng c
024 7 |a 10.1097/SLA.0000000000001850  |2 doi 
035 |a (DE-627)1569803692 
035 |a (DE-576)499803698 
035 |a (DE-599)BSZ499803698 
035 |a (OCoLC)1340987311 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Hackert, Thilo  |d 1971-  |e VerfasserIn  |0 (DE-588)122158512  |0 (DE-627)70579346X  |0 (DE-576)182659208  |4 aut 
245 1 0 |a Locally advanced pancreatic cancer  |b neoadjuvant therapy with folfirinox results in resectability in 60% of the patients  |c Thilo Hackert, Milena Sachsenmaier, Ulf Hinz, Lutz Schneider, Christoph W. Michalski, Christoph Springfeld, Oliver Strobel, Dirk Jäger, Alexis Ulrich, Markus W. Büchler 
264 1 |c September 2016 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 13.02.2018 
520 |a Objective: For patients with locally advanced and unresectable pancreatic cancer (PDAC), neodadjuvant treatment and consecutive surgical exploration have been studied during the last decade with various neoadjuvant therapies including chemotherapy and combinations with radiation. Aim of the study was the evaluation of neoadjuvant therapy with a focus on Folfirinox. Methods: All consecutive patients undergoing surgery for PDAC after neoadjuvant treatment were analyzed (clinico-pathological characteristics, secondary resection rates, outcome). Patients receiving Folfirinox were compared with other treatment regimens. Results: Between December 2001 and June 2015, 575 patients received neoadjuvant treatment and were scheduled for resection after re-staging. A successful resection was achieved in 292 patients (50.8%). Resection rates following Folfirinox were 61% (76/125 patients) compared with 46% (150/322 patients) after gemcitabine and radiation, and 52% (66/128 patients) after other treatments (P = 0.026). Median overall survival was 15.3 months after resection vs 8.5 months after exploration alone (P < 0.0001). Subgroup median survival was 16.0 months (Folfirinox) vs 16.5 months (gemcitabine) and 14.5 months (others) with 3-year survival of 28.1%, 23.2%, and 19.7%, respectively (P = 0.8582). By multivariable analysis, Folfirinox was confirmed to be independently associated with a favorable prognosis. Conclusions: Folfirinox is a valuable treatment option in the neoadjuvant therapy of PDAC. From the present data, which represent the largest available study population to date, Folfirinox seems to be the most effective protocol resulting in a significantly better secondary resection rate and overall survival than other treatments. It should be considered in all patients fit for this regimen and consecutive surgical exploration. 
700 1 |a Sachsenmaier, Milena  |d 1988-  |e VerfasserIn  |0 (DE-588)107157731X  |0 (DE-627)826053688  |0 (DE-576)433162805  |4 aut 
700 1 |a Hinz, Ulf  |e VerfasserIn  |0 (DE-588)1022150499  |0 (DE-627)716927748  |0 (DE-576)175505284  |4 aut 
700 1 |a Schneider, Lutz  |d 1976-  |e VerfasserIn  |0 (DE-588)124284078  |0 (DE-627)706595483  |0 (DE-576)294101799  |4 aut 
700 1 |a Michalski, Christoph  |d 1977-  |e VerfasserIn  |0 (DE-588)129922250  |0 (DE-627)483655848  |0 (DE-576)297904302  |4 aut 
700 1 |a Springfeld, Christoph  |d 1972-  |e VerfasserIn  |0 (DE-588)123388910  |0 (DE-627)706281039  |0 (DE-576)293689385  |4 aut 
700 1 |a Strobel, Oliver  |d 1974-  |e VerfasserIn  |0 (DE-588)123658977  |0 (DE-627)706385101  |0 (DE-576)293812357  |4 aut 
700 1 |a Jäger, Dirk  |d 1964-  |e VerfasserIn  |0 (DE-588)1032507535  |0 (DE-627)738505323  |0 (DE-576)380074125  |4 aut 
700 1 |a Ulrich, Alexis  |e VerfasserIn  |0 (DE-588)1022952226  |0 (DE-627)717337847  |0 (DE-576)177315083  |4 aut 
700 1 |a Büchler, Markus W.  |d 1955-  |e VerfasserIn  |0 (DE-588)120893339  |0 (DE-627)080952526  |0 (DE-576)292434146  |4 aut 
773 0 8 |i Enthalten in  |t Annals of surgery  |d [Erscheinungsort nicht ermittelbar] : Lippincott Williams & Wilkins, 1885  |g 264(2016), 3, Seite 457-463  |h Online-Ressource  |w (DE-627)313115222  |w (DE-600)2002200-1  |w (DE-576)090881796  |x 1528-1140  |7 nnas  |a Locally advanced pancreatic cancer neoadjuvant therapy with folfirinox results in resectability in 60% of the patients 
773 1 8 |g volume:264  |g year:2016  |g number:3  |g pages:457-463  |g extent:7  |a Locally advanced pancreatic cancer neoadjuvant therapy with folfirinox results in resectability in 60% of the patients 
856 4 0 |u http://dx.doi.org/10.1097/SLA.0000000000001850  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://journals.lww.com/annalsofsurgery/Abstract/2016/09000/Locally_Advanced_Pancreatic_Cancer__Neoadjuvant.8.aspx  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180213 
993 |a Article 
994 |a 2016 
998 |g 120893339  |a Büchler, Markus W.  |m 120893339:Büchler, Markus W.  |d 910000  |d 910200  |e 910000PB120893339  |e 910200PB120893339  |k 0/910000/  |k 1/910000/910200/  |p 10  |y j 
998 |g 1022952226  |a Ulrich, Alexis  |m 1022952226:Ulrich, Alexis  |d 910000  |d 910200  |e 910000PU1022952226  |e 910200PU1022952226  |k 0/910000/  |k 1/910000/910200/  |p 9 
998 |g 1032507535  |a Jäger, Dirk  |m 1032507535:Jäger, Dirk  |d 910000  |e 910000PJ1032507535  |k 0/910000/  |p 8 
998 |g 123658977  |a Strobel, Oliver  |m 123658977:Strobel, Oliver  |d 910000  |d 910200  |e 910000PS123658977  |e 910200PS123658977  |k 0/910000/  |k 1/910000/910200/  |p 7 
998 |g 123388910  |a Springfeld, Christoph  |m 123388910:Springfeld, Christoph  |d 910000  |d 910100  |e 910000PS123388910  |e 910100PS123388910  |k 0/910000/  |k 1/910000/910100/  |p 6 
998 |g 129922250  |a Michalski, Christoph  |m 129922250:Michalski, Christoph  |d 910000  |d 910200  |d 50000  |e 910000PM129922250  |e 910200PM129922250  |e 50000PM129922250  |k 0/910000/  |k 1/910000/910200/  |k 0/50000/  |p 5 
998 |g 124284078  |a Schneider, Lutz  |m 124284078:Schneider, Lutz  |d 910000  |d 910200  |e 910000PS124284078  |e 910200PS124284078  |k 0/910000/  |k 1/910000/910200/  |p 4 
998 |g 1022150499  |a Hinz, Ulf  |m 1022150499:Hinz, Ulf  |d 910000  |d 910200  |e 910000PH1022150499  |e 910200PH1022150499  |k 0/910000/  |k 1/910000/910200/  |p 3 
998 |g 107157731X  |a Sachsenmaier, Milena  |m 107157731X:Sachsenmaier, Milena  |d 910000  |d 910200  |e 910000PS107157731X  |e 910200PS107157731X  |k 0/910000/  |k 1/910000/910200/  |p 2 
998 |g 122158512  |a Hackert, Thilo  |m 122158512:Hackert, Thilo  |d 910000  |d 910200  |e 910000PH122158512  |e 910200PH122158512  |k 0/910000/  |k 1/910000/910200/  |p 1  |x j 
999 |a KXP-PPN1569803692  |e 2999137362 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"recId":"313115222","disp":"Locally advanced pancreatic cancer neoadjuvant therapy with folfirinox results in resectability in 60% of the patientsAnnals of surgery","origin":[{"publisherPlace":"[Erscheinungsort nicht ermittelbar] ; [Erscheinungsort nicht ermittelbar]","dateIssuedKey":"1885","dateIssuedDisp":"1885-","publisher":"Lippincott Williams & Wilkins ; Ovid"}],"pubHistory":["1.1885 -"],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 26.09.18"],"id":{"issn":["1528-1140"],"eki":["313115222"],"zdb":["2002200-1"]},"title":[{"title":"Annals of surgery","title_sort":"Annals of surgery","subtitle":"a monthly review of surgical science and practice"}],"part":{"issue":"3","text":"264(2016), 3, Seite 457-463","extent":"7","pages":"457-463","volume":"264","year":"2016"}}],"person":[{"display":"Hackert, Thilo","role":"aut","given":"Thilo","family":"Hackert"},{"display":"Sachsenmaier, Milena","given":"Milena","role":"aut","family":"Sachsenmaier"},{"display":"Hinz, Ulf","family":"Hinz","role":"aut","given":"Ulf"},{"display":"Schneider, Lutz","family":"Schneider","given":"Lutz","role":"aut"},{"family":"Michalski","role":"aut","given":"Christoph","display":"Michalski, Christoph"},{"display":"Springfeld, Christoph","family":"Springfeld","role":"aut","given":"Christoph"},{"display":"Strobel, Oliver","family":"Strobel","role":"aut","given":"Oliver"},{"given":"Dirk","role":"aut","family":"Jäger","display":"Jäger, Dirk"},{"family":"Ulrich","given":"Alexis","role":"aut","display":"Ulrich, Alexis"},{"display":"Büchler, Markus W.","family":"Büchler","role":"aut","given":"Markus W."}],"origin":[{"dateIssuedKey":"2016","dateIssuedDisp":"September 2016"}],"note":["Gesehen am 13.02.2018"],"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"subtitle":"neoadjuvant therapy with folfirinox results in resectability in 60% of the patients","title":"Locally advanced pancreatic cancer","title_sort":"Locally advanced pancreatic cancer"}],"physDesc":[{"extent":"7 S."}],"recId":"1569803692","name":{"displayForm":["Thilo Hackert, Milena Sachsenmaier, Ulf Hinz, Lutz Schneider, Christoph W. Michalski, Christoph Springfeld, Oliver Strobel, Dirk Jäger, Alexis Ulrich, Markus W. Büchler"]},"id":{"eki":["1569803692"],"doi":["10.1097/SLA.0000000000001850"]}} 
SRT |a HACKERTTHILOCALLYADV2016